Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 studyResearch in context by Xi Ding, Yi-Jun Hua, Xiong Zou, Xiao-Zhong Chen, Xi-Mei Zhang, Bei Xu, Yan-Feng Ouyang, Zi-Wei Tu, Hui-Feng Li, Chong-Yang Duan, Wei-Jing Zhang, Rui You, You-Ping Liu, Yong-Long Liu, Qi Yang, Pei-Yu Huang, Shu-Ni Wang, Jia Fan, Ming-Yuan Chen

Get full text

Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study by Meng-Xia Zhang, Ting Liu, Rui You, Xiong Zou, Yong-Long Liu, Xi Ding, Chong-Yang Duan, Han-Shi Xu, You-Ping Liu, Rou Jiang, Zhi-Qiang Wang, Chao Lin, Yu-Long Xie, Si-Yuan Chen, Yan-Feng Ouyang, Ruo-Qi Xie, Yi-Jun Hua, Rui Sun, Pei-Yu Huang, Shun-Lan Wang, Ming-Yuan Chen

Get full text